USANA Health Sciences, Inc. Financial Ratios — USNA Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	31.81	36.96	35.43	31.24	37.05	33.01	18.17	33.47	27.06	31.43	27.85	16.72	13.69	8.17	2.02
Return on Assets (%)	22.64	25.96	24.86	21.32	24.47	22.38	12.63	23.51	18.77	21.53	19.12	11.81	10.38	6.09	1.44
Return on Capital (%)	31.82	36.97	35.43	31.27	37.06	33.12	18.17	33.47	26.78	30.86	27.34	16.47	13.51	7.52	1.68
Return on Invested Capital (%)	30.24	35.23	33.67	29.24	34.19	31.1	16.87	31.08	24.77	29.19	26.13	15.68	11.88	6.38	2.26
Gross Margin (%)	82.53	82.15	82.26	82.19	82.61	82.09	82.87	83.12	82.33	81.57	81.63	80.58	80.82	81.13	78.29
EBITDA Margin (%)	14.73	16.49	17.51	15.8	16.51	15.12	14.19	17.25	15.95	17.54	16.21	12.92	12.32	10.36	9.79
Operating Margin (%)	13.28	15.13	16.25	14.69	15.42	13.78	12.65	15.84	13.78	15.55	14.34	10.78	10.11	7.76	5.5
Incremental Operating Margin (%)	14.06	31.33	26.69	-0.84	19.96	-3.47	-14.86	39.33	32.85	41.09	-12.16	33.31	18.74	40.22	-21.85
Pretax Margin (%)	13.31	15.17	16.23	14.63	15.52	13.77	12.86	16.1	14.19	15.68	14.38	10.88	11.12	8.94	4.49
Profit Margin (%)	8.72	10.24	11	9.69	10.31	9.94	5.97	10.61	9.48	10.99	9.82	6.94	6.93	4.92	1.16
Net Income to Common Margin (%)	8.72	10.24	11	9.69	10.31	9.94	5.97	10.61	9.48	10.99	9.82	6.94	6.93	4.92	1.16
Effective Tax Rate (%)	34.49	32.5	32.22	33.74	33.6	27.8	53.55	34.09	33.2	29.94	31.73	36.15	37.74	44.91	72.36
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	31.81	36.96	35.43	31.24	37.05	33.01	18.17	33.47	27.06	31.43	27.85	16.72	13.69	8.17	2.02

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	8	9	7	7	8	29	20
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	8	9	7	7	8	29	20
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	0.05	0.04	0.04	0.05	0.07	0.33	0.22
Net Debt/EBITDA	-0.59	-0.66	-1.09	-0.89	-0.94	-1.16	-1.66	-1.04	-1.39	-1.57	-1.25	-2.24	-2.91	-1.79	-1.59
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	0.06	0.05	0.04	0.06	0.09	0.44	0.39
Net Debt/EBIT	-0.65	-0.72	-1.18	-0.96	-1.01	-1.27	-1.87	-1.14	-1.61	-1.77	-1.41	-2.68	-3.54	-2.39	-2.84
EBITDA to Interest Expense	9,525.56	5,350.25	125,756	968.31	10,109.33	342.58	3,230.74	5,699.89	2,563.59	392.5	3,375.18	672	433.08	315.14	107.56
EBITDA-CapEx/Interest Expense	8,343	4,928.65	117,705	810.01	8,527.4	268.93	2,943.35	5,382.31	2,312.55	362.73	3,151.26	617.83	377.76	279.29	91.14
EBIT to Interest Expense	8,584	4,908.95	116,712	900.02	9,444.13	312.21	2,880.52	5,232.03	2,215	348.11	2,985.82	560.49	355.23	236.03	60.41
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	- -	- -	- -	1
Common Equity/Total Assets	71.13	69.41	70.7	65.65	66.36	69.12	69.95	70.55	68.04	68.91	68.39	72.83	78.58	71.12	71.76
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	2.37	1.95	1.79	1.59	1.62	4.95	3.35
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	2.31	1.91	1.76	1.56	1.6	4.71	3.24
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	1.61	1.34	1.23	1.16	1.27	3.88	2.64
Net Debt to Equity	-28.95	-38.17	-52.72	-48.28	-50.99	-54.04	-68.04	-54.79	-66.77	-70.63	-60.7	-66.38	-66.3	-27.08	-24.63
Net Debt/Capital (%)	-40.75	-61.74	-111.5	-93.35	-104.05	-117.56	-212.9	-121.21	-187.56	-225.46	-147.71	-188.58	-188.53	-36.62	-32.26
EBITDA	86	107	126	125	152	152	149	205	169	199	192	129	113	89	91
EBITDA-CapEx	75	99	118	104	128	119	135	194	153	184	180	119	99	78	77
Operating Income (Loss)	77	98	117	116	142	139	133	188	146	176	170	108	93	66	51

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.84	1	1.52	1.02	1.09	1.27	1.75	1.87	1.73	1.86	1.49	2.01	2.78	1.3	1.23
Current Ratio	1.78	1.87	2.39	1.76	1.86	2.01	2.41	2.64	2.42	2.53	2.27	2.67	3.52	2	2.24
Quick Ratio	0.94	1.12	1.66	1.12	1.18	1.39	1.85	1.96	1.79	1.9	1.54	2.06	2.84	1.36	1.3
CFO/Avg Current Liab	1.2	1.42	1.19	1.03	0.93	1.01	0.89	1.05	0.89	1.05	0.74	0.68	0.54	0.47	0.17
Common Equity/Total Assets	71.13	69.41	70.7	65.65	66.36	69.12	69.95	70.55	68.04	68.91	68.39	72.83	78.58	71.12	71.76
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	2.37	1.95	1.79	1.59	1.62	4.95	3.35
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	2.31	1.91	1.76	1.56	1.6	4.71	3.24
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	1.61	1.34	1.23	1.16	1.27	3.88	2.64
CFO/Total Liabilities	99.32	113.48	91.61	87.35	78.28	94.18	79.31	93.14	76.7	80.51	66.38	64.11	52.11	37.68	14.27
CFO/CapEx	6.59	11.01	12.28	5.15	4.7	4.19	9.36	13.31	7.65	10.63	9.5	9.99	4.87	6.05	1.62
Altman's Z-Score	9.61	9.3	10.85	11.62	11.68	10.96	11.4	15.26	10.86	9.21	11.12	7.79	8.31	6.76	5.48

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	173.38	435.68	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	2.11	0.84	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	2.86	3.15	3.04	3.04	2.87	2.75	2.81	2.77	2.49	2.63	2.31	2.34	2.75	2.46	2.33
Days Inventory Outstanding	127.5	115.75	119.9	119.89	127.28	132.61	129.93	131.72	146.83	138.88	157.91	155.69	132.77	148.51	156.6
Accounts Payable Turnover	14.53	15.38	16.71	16.06	20.26	18.75	17.05	20.22	15.53	15	14.26	13.25	16.2	15.37	15.98
Accounts Payable Turnover Days	25.12	23.73	21.85	22.72	18.01	19.47	21.41	18.05	23.51	24.33	25.6	27.55	22.53	23.75	22.84
Cash Conversion Cycle	104.48	92.86	98.05	97.17	109.27	113.14	108.52	113.67	123.32	114.55	132.31	128.14	110.24	124.77	133.76
Inventory to Cash Days	-125.4	-114.91	-119.9	-119.89	-127.28	-132.61	-129.93	-131.72	-146.83	-138.88	-157.91	-155.69	-132.77	-148.51	-156.6
Inventories	37	36	47	45	66	65	63	82	69	90	98	67	61	70	103
Raw Materials	10	9	14	15	23	26	21	20	16	28	30	22	20	24	32
Work In Process	7	8	8	8	9	9	8	14	12	10	10	4	5	4	5
Finished Goods	20	20	25	23	35	29	34	48	41	52	58	41	37	42	66
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	454	455	1,050	1,296	1,595	1,498	1,779	2,775	1,701	1,622	1,963	1,022	1,025	684	359
- Cash & Cash Equivalents	50	71	137	111	143	176	247	214	235	312	240	288	330	182	158
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	54	53
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	8	9	7	7	8	29	20
Enterprise Value	403	384	904	1,185	1,452	1,323	1,532	2,497	1,474	1,319	1,730	740	703	586	273
Total Capital	174	186	261	230	281	325	363	391	360	450	402	441	505	615	606
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	2.31	1.91	1.76	1.56	1.6	4.71	3.24
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	0.01	0.01	- -	0.01	0.01	0.05	0.07
EV/Sales	0.69	0.59	1.26	1.5	1.58	1.31	1.46	2.1	1.39	1.16	1.46	0.74	0.76	0.69	0.3
EV/EBITDA	4.71	3.59	7.18	9.49	9.58	8.7	10.31	12.17	8.71	6.63	8.99	5.74	6.2	6.61	3.02
EV/EBIT	5.22	3.91	7.74	10.21	10.25	9.54	11.56	13.26	10.09	7.47	10.16	6.88	7.55	8.83	5.37
EV/Cash Flow to Firm	5.75	4.14	9.14	11.26	13.03	9.64	12.37	16.41	11.63	8.2	14.26	7.12	9.93	9.58	12.1
EV/Free Cash Flow to Firm	4.99	3.8	8.45	9.43	10.74	7.78	11.18	15.26	10.29	7.5	12.91	6.47	8.24	8.22	7.51
Diluted Market Cap	473	491	1,074	1,404	1,683	1,533	1,830	2,901	1,792	1,639	2,059	1,027	1,037	688	365
Diluted Enterprise Value	423	421	936	1,293	1,540	1,357	1,582	2,687	1,566	1,336	1,826	746	715	589	279
EV per Share	13.5	13.9	32.53	46.9	58.14	54.02	63.76	105.94	68.09	62.68	89.2	38.54	36.75	30.72	14.95
TTM Sales	582	649	718	790	918	1,006	1,047	1,189	1,061	1,135	1,186	999	921	855	925
TTM EBITDA	86	107	126	125	152	152	149	205	169	199	192	129	113	89	91
TTM Operating Income	77	98	117	116	142	139	133	188	146	176	170	108	93	66	51
TTM Cash Flow to Firm	70	93	99	105	111	137	124	152	127	161	121	104	71	61	23
TTM Free Cash Flow to Firm	81	101	107	126	135	170	137	164	143	176	134	114	85	71	36

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	5.86	4.85	10.04	11.18	12.45	9.04	13.36	17.74	12.51	9.34	15.36	8.99	12.18	9.68	10.08
EV/EBIT	5.22	3.91	7.74	10.21	10.25	9.54	11.56	13.26	10.09	7.47	10.16	6.88	7.55	8.83	5.37
Enterprise Value	403	384	904	1,185	1,452	1,323	1,532	2,497	1,474	1,319	1,730	740	703	586	273
Low Price	11.55	15.26	16.02	27.5	48.02	46	52.55	69.55	58.3	43.01	77.06	48.61	44.01	31.44	18.48
EV/Sales	0.69	0.59	1.26	1.5	1.58	1.31	1.46	2.1	1.39	1.16	1.46	0.74	0.76	0.69	0.3
EV/EBITDA	4.71	3.59	7.18	9.49	9.58	8.7	10.31	12.17	8.71	6.63	8.99	5.74	6.2	6.61	3.02
Price/Earnings	8.94	6.85	13.28	16.91	16.85	14.98	28.45	21.98	16.92	13.01	16.85	14.73	16.07	16.28	33.35
Price/Earnings Average	9.41	8.41	11.45	12.98	16.54	15.32	23.75	19.96	17.42	12.9	16.13	19.7	17.72	19.64	47.28
Price/Earnings High	13.02	10.45	16.17	19.59	23.33	18.36	29.25	25.76	25.71	15.57	17.95	28.6	20.87	24.86	65.1
Price/Earnings Low	6.8	6.35	5.63	9.07	12.67	11.26	20.19	12.99	12.56	7.26	12.83	13.46	13.2	14.26	31.4
Price/Book Value	2.61	2.45	4.03	5.63	5.68	4.61	4.9	7.09	4.84	3.67	4.97	2.35	2.06	1.29	0.67
Price/Book Value Average	2.75	3.01	3.47	4.32	5.58	4.71	4.09	6.44	4.98	3.64	4.76	3.14	2.27	1.55	0.95
Price/Book Value High	3.8	3.74	4.9	6.52	7.86	5.65	5.04	8.31	7.35	4.39	5.29	4.56	2.68	1.96	1.31
Price/Book Value Low	1.98	2.27	1.71	3.02	4.27	3.46	3.48	4.19	3.59	2.05	3.78	2.15	1.69	1.13	0.63
Price/Tangible Book Value	4	3.62	5.25	7.57	7.09	5.46	5.73	8.1	5.57	4.12	5.66	2.66	2.28	2.9	1.37
Price/Tangible Book Value Average	4.21	4.45	4.53	5.81	6.96	5.59	4.78	7.35	5.74	4.09	5.42	3.55	2.51	3.5	1.94
Price/Tangible Book Value High	5.82	5.53	6.39	8.77	9.81	6.7	5.89	9.49	8.47	4.93	6.03	5.16	2.96	4.43	2.67
Price/Tangible Book Value Low	3.04	3.36	2.22	4.06	5.33	4.11	4.06	4.79	4.14	2.3	4.31	2.43	1.87	2.54	1.29
Price/Sales	0.78	0.7	1.46	1.64	1.74	1.49	1.7	2.33	1.6	1.43	1.65	1.02	1.11	0.8	0.39
Price/Sales Average	0.82	0.86	1.26	1.26	1.7	1.52	1.42	2.12	1.65	1.42	1.58	1.37	1.23	0.97	0.55
Price/Sales High	1.14	1.07	1.78	1.9	2.4	1.83	1.75	2.73	2.44	1.71	1.76	1.99	1.45	1.22	0.76
Price/Sales Low	0.59	0.65	0.62	0.88	1.31	1.12	1.21	1.38	1.19	0.8	1.26	0.93	0.91	0.7	0.37
Price/Cash Flow	6.47	4.9	10.61	12.32	14.31	10.95	14.37	18.24	13.42	10.11	16.19	9.83	14.52	11.22	16.06
Price/Cash Flow Average	6.81	6.02	9.15	9.46	14.05	11.2	12	16.56	13.82	10.03	15.5	13.15	16	13.53	22.76
Price/Cash Flow High	9.42	7.48	12.92	14.27	19.82	13.41	14.78	21.37	20.4	12.1	17.25	19.09	18.85	17.13	31.34
Price/Cash Flow Low	4.92	4.54	4.5	6.61	10.76	8.23	10.2	10.78	9.96	5.64	12.33	8.99	11.92	9.83	15.12
Price/Free Cash Flow Average	6.17	5.96	8.65	8.58	12.22	9.25	11.15	16.1	12.87	9.26	14.71	12.01	13.43	11.67	14.29
Price/Free Cash Flow High	8.53	7.4	12.22	12.95	17.24	11.08	13.73	20.78	19.01	11.17	16.37	17.44	15.82	14.78	19.68
Price/Free Cash Flow Low	4.46	4.5	4.25	6	9.36	6.79	9.48	10.48	9.28	5.21	11.7	8.21	10	8.48	9.49
EV/Sales Average	0.73	0.75	1.07	1.12	1.55	1.35	1.18	1.94	1.44	1.15	1.39	1.09	0.88	0.85	0.46
EV/Sales High	1.05	0.96	1.59	1.76	2.25	1.65	1.51	2.55	2.22	1.44	1.57	1.7	1.1	1.11	0.66
EV/Sales Low	0.51	0.54	0.43	0.74	1.15	0.94	0.97	1.2	0.98	0.53	1.06	0.65	0.56	0.59	0.27
EV/EBITDA Average	4.99	4.56	6.1	7.07	9.38	8.92	8.33	11.23	9.01	6.56	8.56	8.4	7.12	8.21	4.67
EV/EBITDA High	7.12	5.83	9.07	11.13	13.62	10.92	10.65	14.8	13.94	8.23	9.66	13.19	8.89	10.69	6.79
EV/EBITDA Low	3.44	3.28	2.44	4.67	6.96	6.25	6.83	6.94	6.12	3.02	6.56	5.05	4.58	5.66	2.79
EV/EBIT Average	5.53	4.97	6.58	7.61	10.04	9.79	9.34	12.24	10.43	7.39	9.67	10.08	8.68	10.96	8.32
EV/EBIT High	7.9	6.35	9.77	11.97	14.58	11.98	11.94	16.12	16.13	9.28	10.92	15.81	10.84	14.27	12.09
EV/EBIT Low	3.82	3.57	2.63	5.03	7.46	6.86	7.66	7.56	7.09	3.41	7.41	6.06	5.58	7.55	4.96
Last Price	15.18	16.46	37.79	51.3	63.88	61.2	74.05	117.73	78.55	77.1	101.2	53.2	53.6	35.89	19.63
High Price	22.11	25.12	46	59.42	88.44	75	76.15	137.95	119.37	92.26	107.85	103.26	69.6	54.81	38.32
Enterprise Value Average	427	488	767	883	1,423	1,357	1,238	2,305	1,524	1,305	1,646	1,084	808	727	423
Enterprise Value High	610	623	1,140	1,390	2,066	1,661	1,582	3,037	2,358	1,638	1,859	1,702	1,009	946	615
Enterprise Value Low	295	351	307	584	1,056	951	1,015	1,425	1,036	602	1,262	652	520	501	252

Shares Outstanding	30	28	28	25	25	24	24	24	22	21	19	19	19	19	18
Diluted Weighted Avg Shares	31	30	28	27	26	25	25	25	23	21	20	19	19	19	19
Basic Weighted Avg Shares	30	28	28	25	25	24	24	24	22	21	19	19	19	19	18
Revenue per Share	19.48	23.47	25.86	31.29	36.78	41.09	43.59	50.46	48.99	53.93	61.18	51.99	48.14	44.82	50.61
EBITDA per Share	2.87	3.87	4.53	4.94	6.07	6.21	6.19	8.71	7.81	9.46	9.92	6.72	5.93	4.65	4.95
Operating Income per Share	2.59	3.55	4.2	4.6	5.67	5.66	5.52	7.99	6.75	8.39	8.78	5.6	4.87	3.48	2.78
Basic EPS, GAAP	1.7	2.4	2.85	3.03	3.79	4.09	2.6	5.36	4.64	5.93	6.01	3.61	3.33	2.2	0.59
Basic EPS from Cont Ops	1.7	2.4	2.85	3.03	3.79	4.09	2.6	5.36	4.64	5.93	6.01	3.61	3.33	2.21	0.63
Diluted EPS, GAAP	1.63	2.23	2.78	2.8	3.59	3.99	2.53	5.12	4.41	5.86	5.73	3.59	3.3	2.19	0.58
Diluted EPS from Cont Ops	1.63	2.23	2.78	2.8	3.59	3.99	2.53	5.12	4.41	5.86	5.73	3.59	3.3	2.19	0.62
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	2.35	3.36	3.56	4.16	4.46	5.59	5.15	6.45	5.85	7.62	6.25	5.41	3.69	3.2	1.22
Free Cash Flow per Basic Share	1.99	3.05	3.27	3.35	3.51	4.26	4.6	5.97	5.09	6.91	5.59	4.87	2.94	2.67	0.47
Cash & Equivalents per Share	1.69	2.56	5.26	4.4	5.73	7.18	10.29	11.79	10.84	14.83	12.37	15.02	17.27	9.53	8.66
Book Value per Share	5.82	6.71	9.38	9.11	11.24	13.29	15.12	16.6	16.24	20.99	20.37	22.62	25.99	27.91	29.16
Tangible Book Value per Share	3.8	4.54	7.2	6.78	9.01	11.2	12.93	14.53	14.1	18.7	17.89	20.03	23.53	12.39	14.33

USANA Health Sciences, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)